Leavell Investment Management buys $5,771,131 stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Leavell Investment Management scooped up 1,500 additional shares in Colgate-Palmolive Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 18, 2016. The investment management firm now holds a total of 77,862 shares of Colgate-Palmolive Company which is valued at $5,771,131.Colgate-Palmolive Company makes up approximately 0.83% of Leavell Investment Management’s portfolio.

Other Hedge Funds, Including , Cribstone Capital Management reduced its stake in CL by selling 879 shares or 11.36% in the most recent quarter. The Hedge Fund company now holds 6,858 shares of CL which is valued at $508,315. Colgate-Palmolive Company makes up approx 0.32% of Cribstone Capital Management’s portfolio. Deroy Devereaux Private Investment Counsel Inc sold out all of its stake in CL during the most recent quarter. The investment firm sold 3,000 shares of CL which is valued $223,410.Huntington Steele reduced its stake in CL by selling 76 shares or 1.5% in the most recent quarter. The Hedge Fund company now holds 4,998 shares of CL which is valued at $372,201. Colgate-Palmolive Company makes up approx 0.14% of Huntington Steele’s portfolio.Webster Bank N. A. reduced its stake in CL by selling 100 shares or 2.64% in the most recent quarter. The Hedge Fund company now holds 3,688 shares of CL which is valued at $274,645. Colgate-Palmolive Company makes up approx 0.04% of Webster Bank N. A.’s portfolio.

Colgate-Palmolive Company closed down -0.05 points or -0.07% at $74.12 with 29,61,822 shares getting traded on Wednesday. Post opening the session at $74.27, the shares hit an intraday low of $74.09 and an intraday high of $74.51 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

On the company’s financial health, Colgate-Palmolive Company reported $0.63 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.63. The company had revenue of $3762.00 million for the quarter, compared to analysts expectations of $3760.63 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.66 EPS.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by Goldman to ” Neutral” on May 2, 2016. Company shares were Reiterated by UBS on Apr 29, 2016 to “Neutral”, Firm has raised the Price Target to $ 76 from a previous price target of $73 .

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.